Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:735-740

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, X.-P.
Right arrow Articles by Carretero, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, X.-P.
Right arrow Articles by Carretero, O. A.

(Hypertension. 1997;30:735.)
© 1997 American Heart Association, Inc.


Articles

Role of Kinins in the Cardioprotective Effect of Preconditioning

Study of Myocardial Ischemia/Reperfusion Injury in B2 Kinin Receptor Knockout Mice and Kininogen-Deficient Rats

Xiao-Ping Yang; Yun-He Liu; Gloria M. Scicli; Charles R. Webb; Oscar A. Carretero

From the Hypertension and Vascular Research Division and the Electrophysiology Laboratory (C.R.W.), Division of Cardiology, Department of Medicine, Henry Ford Hospital, Detroit, Mich.

Correspondence to Xiao-Ping Yang, MD, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202.

Abstract Kinins acting on the B2 receptor appear to be involved in the cardioprotective effect of preconditioning on myocardial ischemia/reperfusion injury. We tested the hypothesis that in mice lacking the gene encoding for the B2 kinin receptor (B2 knockout mice; B2-KO) as well as in rats deficient in high-molecular-weight (HMW) kininogen (Brown Norway Katholiek rats; BNK), the cardioprotective effect of preconditioning is diminished or abolished. 129SvEvTac (SV129) mice and Brown Norway rats (BN) served as controls. We confirmed that plasma HMW kininogen in BNK rats was 100-fold lower than in BN and 140-fold lower than in Sprague-Dawley rats (33±4 versus 1814±253 and 2397±302 ng/mL, P<.01). Each strain of mice was divided into (1) controls (without preconditioning); (2) one cycle of preconditioning (3 minutes ligation and 5 minutes reperfusion); and (3) three cycles of preconditioning. Each strain of rats was divided into (1) controls; and (2) three cycles of preconditioning. All animals were subjected to 30 minutes of ischemia and 120 minutes of reperfusion. In SV129 controls, the ratio of infarct size to risk area (IS/AR) was 55.6±4.6%. One and three cycles of preconditioning reduced IS/AR to 38.6±3.2% and 31.1±2.3%, respectively (P<.05 and P<.01 versus control). This protective effect was absent in B2-KO mice: IS/AR was 54.8±2.9% in controls, 58.5±3.6% with one cycle of preconditioning, and 58.5±3.4% with three cycles. In BN rats without preconditioning, IS/AR was 84.7±3.9%; preconditioning reduced it to 61.6±3.4% (P<.01). In BNK rats, IS/AR was 87.1±4.8% in controls and 84.3±4.1% with preconditioning. Preconditioning also prevented reperfusion arrhythmias in BN but not BNK rats. Within species, risk area, mean blood pressure, and heart rate were similar between strains. We concluded that (1) preconditioning protects the heart against ischemia/reperfusion injury in mice and rats; (2) activation of prekallikrein, which in turn generates kinins from HMW kininogen, may contribute to the effect of preconditioning; and (3) an intact kallikrein-kinin system is necessary for the cardioprotective effect of preconditioning.


Key Words: mice, kinin B2 receptor, knockout • rats • kininogens • ischemia/reperfusion injury




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Naitoh, T. Yano, T. Miura, T. Itoh, T. Miki, M. Tanno, T. Sato, H. Hotta, Y. Terashima, and K. Shimamoto
Roles of Cx43-associated protein kinases in suppression of gap junction-mediated chemical coupling by ischemic preconditioning
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H396 - H403.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Chao, H. Yin, L. Gao, M. Hagiwara, B. Shen, Z.-R. Yang, and L. Chao
Tissue Kallikrein Elicits Cardioprotection by Direct Kinin B2 Receptor Activation Independent of Kinin Formation
Hypertension, October 1, 2008; 52(4): 715 - 720.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Xi, A. Das, Z.-Q. Zhao, V. F. Merino, M. Bader, and R. C. Kukreja
Loss of Myocardial Ischemic Postconditioning in Adenosine A1 and Bradykinin B2 Receptors Gene Knockout Mice
Circulation, September 30, 2008; 118(14_suppl_1): S32 - S37.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Duka, E. Kintsurashvili, I. Duka, D. Ona, T. A. Hopkins, M. Bader, I. Gavras, and H. Gavras
Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors
Hypertension, May 1, 2008; 51(5): 1352 - 1357.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Vinten-Johansen, Z.-Q. Zhao, R. Jiang, A. J. Zatta, and G. P. Dobson
Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury
J Appl Physiol, October 1, 2007; 103(4): 1441 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Penna, D. Mancardi, R. Rastaldo, G. Losano, and P. Pagliaro
Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling
Cardiovasc Res, July 1, 2007; 75(1): 168 - 177.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Cayla, M. Todiras, R. Iliescu, V. V. Saul, V. Gross, B. Pilz, G. Chai, V. F. Merino, J. B. Pesquero, O. C. Baltatu, et al.
Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension
FASEB J, June 1, 2007; 21(8): 1689 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S.-J. Kim, X. Zhang, X. Xu, A. Chen, J. B. Gonzalez, S. Koul, K. Vijayan, G. J. Crystal, S. F. Vatner, and T. H. Hintze
Evidence for enhanced eNOS function in coronary microvessels during the second window of protection
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2152 - H2158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Duka, I. Duka, G. Gao, S. Shenouda, I. Gavras, and H. Gavras
Role of bradykinin B1 and B2 receptors in normal blood pressure regulation
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E268 - E274.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. R. Gross and G. J. Gross
Ligand triggers of classical preconditioning and postconditioning
Cardiovasc Res, May 1, 2006; 70(2): 212 - 221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Kintsurashvili, A. Duka, I. Ignjacev, G. Pattakos, I. Gavras, and H. Gavras
Age-related changes of bradykinin B1 and B2 receptors in rat heart
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H202 - H205.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Xu, O. A. Carretero, Y. Sun, E. G. Shesely, N.-E. Rhaleb, Y.-H. Liu, T.-D. Liao, J. J. Yang, M. Bader, and X.-P. Yang
Role of the B1 Kinin Receptor in the Regulation of Cardiac Function and Remodeling After Myocardial Infarction
Hypertension, April 1, 2005; 45(4): 747 - 753.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y.-H. Liu, X.-P. Yang, E. G. Shesely, S. S. Sankey, and O. A. Carretero
Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure
J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1473 - 1480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Schanstra, J. Duchene, F. Praddaude, P. Bruneval, I. Tack, J. Chevalier, J.-P. Girolami, and J.-L. Bascands
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1904 - H1908.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Kuoppala, N. Shiota, J. O. Kokkonen, I. Liesmaa, K. Kostner, M. Mayranpaa, P. T. Kovanen, and K. A. Lindstedt
Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure
J. Am. Coll. Cardiol., July 3, 2002; 40(1): 119 - 125.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Trabold, S. Pons, A. A. Hagege, M. Bloch-Faure, F. Alhenc-Gelas, J.-F. Giudicelli, C. Richer-Giudicelli, and P. Meneton
Cardiovascular Phenotypes of Kinin B2 Receptor- and Tissue Kallikrein-Deficient Mice
Hypertension, July 1, 2002; 40(1): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. He, D. Wang, X.-P. Yang, O. A. Carretero, and M. C. LaPointe
Inducible regulation of human brain natriuretic peptide promoter in transgenic mice
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H368 - H376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Shigematsu, S. Ishida, D. C. Gute, and R. J. Korthuis
Postischemic anti-inflammatory effects of bradykinin preconditioning
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H441 - H454.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. D. Figueroa, A. Marchant, U. Novoa, U. Forstermann, K. Jarnagin, B. Scholkens, and W. Muller-Esterl
Differential Distribution of Bradykinin B2 Receptors in the Rat and Human Cardiovascular System
Hypertension, January 1, 2001; 37(1): 110 - 120.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N.-E. Rhaleb, X.-P. Yang, M. Nanba, E. G. Shesely, and O. A. Carretero
Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats
Hypertension, January 1, 2001; 37(1): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. G. McLean, M. Perretti, and A. Ahluwalia
Kinin B1 receptors and the cardiovascular system: regulation of expression and function
Cardiovasc Res, November 1, 2000; 48(2): 194 - 210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, R. Jones, A. M. Byford, A. R. Stell, J. Peart, J. P. Headrick, and G. P. Matherne
Transgenic overexpression of cardiac A1 adenosine receptors mimics ischemic preconditioning
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1071 - H1078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H.-L. Pan, S.-R. Chen, G. M. Scicli, and O. A. Carretero
Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H116 - H121.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
M. Schachter
ACE inhibitors, angiotensin receptor antagonists and bradykinin
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1): 27 - 29.
[PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-H. Liu, X.-P. Yang, D. Mehta, M. Bulagannawar, G. M. Scicli, and O. A. Carretero
Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats
Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H507 - H514.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-P. Yang, Y.-H. Liu, N.-E. Rhaleb, N. Kurihara, H. E. Kim, and O. A. Carretero
Echocardiographic assessment of cardiac function in conscious and anesthetized mice
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1967 - H1974.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. Linz, P. Wohlfart, B. A Scholkens, T. Malinski, and G. Wiemer
Interactions among ACE, kinins and NO
Cardiovasc Res, August 15, 1999; 43(3): 549 - 561.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Shigematsu, S. Ishida, D. C. Gute, and R. J. Korthuis
Bradykinin prevents postischemic leukocyte adhesion and emigration and attenuates microvascular barrier disruption
Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H161 - H171.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X.-P. Yang, Y.-H. Liu, E. G. Shesely, M. Bulagannawar, F. Liu, and O. A. Carretero
Endothelial Nitric Oxide Gene Knockout Mice : Cardiac Phenotypes and the Effect of Angiotensin-Converting Enzyme Inhibitor on Myocardial Ischemia/Reperfusion Injury
Hypertension, July 1, 1999; 34(1): 24 - 30.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N.-E. Rhaleb, H. Peng, M. E. Alfie, E. G. Shesely, and O. A. Carretero
Effect of ACE Inhibitor on DOCA-Salt– and Aortic Coarctation–Induced Hypertension in Mice : Do Kinin B2 Receptors Play a Role?
Hypertension, January 1, 1999; 33(1): 329 - 334.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X.-P. Yang, Y.-H. Liu, D. Mehta, M. A. Cavasin, E. Shesely, J. Xu, F. Liu, and O. A. Carretero
Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B2 Kinin Receptor Gene Knockout Mice
Circ. Res., May 25, 2001; 88(10): 1072 - 1079.
[Abstract] [Full Text] [PDF]